Pharmacology, Toxicology and Pharmaceutical Science
Candida Albicans
82%
Candida
79%
Lung Aspergillosis
78%
Antifungal Agent
69%
Pyrrole
63%
Aspergillus
49%
Disease
48%
Infection
41%
Resistance to Antifungal Agent
41%
Candidiasis
37%
Fluconazole
36%
Candidemia
34%
Infectious Agent
32%
Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy
28%
Isavuconazole
28%
Pyrrole Derivative
25%
Chlorhexidine
25%
Antiinfective Agent
25%
Voriconazole
24%
Candida Auris
22%
Posaconazole
22%
Aspergillus fumigatus
21%
Vagina Candidiasis
21%
Cohort Study
21%
Itraconazole
19%
Adverse Event
18%
Coronavirinae
18%
Volatile Organic Compound
18%
Therapeutic Drug Monitoring
18%
Skin Injury
18%
Prevalence
18%
Thrush
17%
Echinocandin
17%
Mycosis
16%
Antifungal Therapy
13%
Caspofungin
12%
Biological Marker
12%
Aspergillosis
12%
Mucocutaneous Candidiasis
11%
Observational Study
11%
Tooth Infection
11%
Amphotericin B
11%
Galactomannan
11%
Lung Tuberculosis
11%
Triazole
10%
Base
10%
Wound Infection
10%
Micafungin
10%
Glucan
10%
Effusion
9%
Medicine and Dentistry
Infection
100%
Candidiasis
76%
Candidemia
62%
Antifungal Agent
57%
Aspergillus
48%
Diagnosis
44%
Medical Mycology
42%
Chronic Pulmonary Aspergillosis
39%
Pathogen
32%
Antifungal Resistance
29%
Dental Procedure
28%
Chronic Hyperplastic Candidosis
28%
Mycosis
26%
Hospital Care
26%
Odontogenic Infection
26%
Diseases
25%
Polymerase Chain Reaction
25%
Cohort Analysis
24%
Systemic Mycosis
23%
Protocol Compliance
21%
Pyrrole
21%
Mouth Infection
21%
Vagina Candidiasis
21%
Aspergillus fumigatus
20%
Toll Like Receptor
20%
Cooperation
20%
Chronic Periodontitis
20%
In Vitro
19%
Sputum
19%
Dental Treatment
19%
Real-Time Polymerase Chain Reaction
18%
Skin Injury
18%
Volatile Organic Compound
18%
Extracorporeal Membrane Oxygenation
18%
Cohort Study
18%
Chlorhexidine
18%
Prevalence
18%
Bloodstream Infection
17%
Antifungal Therapy
16%
Abscess
14%
Systemic Disease
14%
Epithelial Cell
14%
Cohort Effect
13%
Biological Marker
12%
Cystic Fibrosis
12%
Complement Membrane Attack Complex
12%
Tooth Extraction
12%
Agar
12%
Human Immunodeficiency Virus
11%
Clinical Feature
11%
Immunology and Microbiology
Candida Albicans
98%
Candida
94%
Biofilm
88%
Aspergillus
88%
Infectious Agent
46%
Antifungal Resistance
45%
Aspergillus fumigatus
42%
Autoimmune Polyendocrine Syndrome Type 1
37%
Medical Mycology
33%
Polymerase Chain Reaction
30%
Real-Time Polymerase Chain Reaction
30%
Squamous Cell
28%
CD59 Antigen
28%
Periodontitis
28%
Serology
26%
Toll-Like Receptor
26%
Pneumocystis Jiroveci
22%
Sputum
22%
CD59
22%
Candida Auris
21%
TLR 1
19%
Teeth
19%
COVID-19
18%
Pyrosequencing
18%
P53
18%
Prevalence
18%
Microbiome
16%
Microorganism
15%
Minimum Inhibitory Concentration
15%
Surface Property
14%
Pneumocystis
13%
Periodontium
13%
Gingival Tissue
11%
Human Immunodeficiency Virus
11%
Molecular Epidemiology
11%
Laboratory Test
11%
Mucosa
11%
Mould
10%
Pseudomonas aeruginosa
9%
Opsonophagocytosis
9%
Coronavirinae
9%
Genotype
9%
Alpha Defensin
9%
Transcriptome
9%
Sampling
9%
Exophiala
9%
Transplant Procedure
9%
Helicobacter Pylori
9%
Pathogenicity
9%
Chlorhexidine
9%